Monthly Prescribing Reference2d
Empagliflozin, Dapagliflozin Comparably Reduce AKI, CKD Risks in Diabetes Population
No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.
Daily1d
Empagliflozin and dapagliflozin have comparable long-term kidney outcomes in Type 2 Diabetes: JAMA
The results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or ...
pharmaphorum2y
FDA approves Jardiance (empagliflozin) for wider range of patients with heart failure
Eli Lilly and Boehringer Ingelheim's blockbuster diabetes drug Jardiance (empagliflozin) has been granted approval by the US Food and Drug Administration (FDA) for a wider range of heart failure ...
Verywell Health on MSN10mon
Jardiance vs. Farxiga: Similarities and Differences
The Food and Drug Administration (FDA) has approved the following uses for both Jardiance and Farxiga: Jardiance is also ...
Hosted on MSN2d
No Clear Winner in SGLT2 Showdown for Cardiovascular Disease
Taken at face value, the results would suggest that the three SGLT2 inhibitors are "virtually identical," according to ...